| abstract |
Novel 7-azaindole derivatives of the formula (I), in which U, L, R, Y, X 1 , X 2 and X 3 have the meanings indicated in Claim 1 ), are kinase inhibitors and can be used for the treatment of diseases and conditions such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in any type of fibroses, inflammatory processes, tumours and tumour diseases. |